| 1 |
Kario K, Wang JG. Toward “zero” cardiovascular events in Asia: the HOPE Asia Network. JACC: Asia. 2021; 1(1):121-4.
doi: 10.1016/j.jacasi.2021.03.003
|
| 2 |
National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7.
doi: 10.1056/NEJM199512143332401
|
| 3 |
Hill MD, Buchan AM, Canadian Alteplase for Stroke Effectiveness Study I. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005; 172(10):1307-12.
doi: 10.1503/cmaj.1041561
|
| 4 |
Rababah JA, Al-Hammouri MM, Al-AlNsour E. Effectiveness of an educational program on improving healthcare providers' knowledge of acute stroke: a randomized block design study. World J Emerg Med. 2021; 12(2):93-8.
doi: 10.5847/wjem.j.1920-8642.2021.02.002
pmid: 33728000
|
| 5 |
Engelter ST, Fluri F, Buitrago-Tellez C, Marsch S, Steck AJ, Ruegg S, et al. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol. 2005; 252(10):1167-70.
pmid: 16184341
|
| 6 |
Lin SY, Tang SC, Tsai LK, Yeh SJ, Hsiao YJ, Chen YW, et al. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use. Eur J Neurol. 2014; 21(10):1285-91.
doi: 10.1111/ene.12472
pmid: 24909847
|
| 7 |
Wang YX, Li YQ, Chen Y, Zhang CH, Dong Z, Wang Z, et al. Analysis of related factors of orolingual angioedema after rt-PA intravenous thrombolytic therapy. Eur Rev Med Pharmacol Sci. 2018; 22(5):1478-84.
|
| 8 |
Myslimi F, Caparros F, Dequatre-Ponchelle N, Moulin S, Gautier S, Girardie P, et al. Orolingual angioedema during or after thrombolysis for cerebral ischemia. Stroke. 2016; 47(7):1825-30.
doi: 10.1161/STROKEAHA.116.013334
pmid: 27197851
|
| 9 |
Correia AS, Matias G, Calado S, Lourenco A, Viana-Baptista M. Orolingual angiodema associated with alteplase treatment of acute stroke: a reappraisal. J Stroke Cerebrovasc Dis. 2015; 24(1):31-40.
doi: 10.1016/j.jstrokecerebrovasdis.2014.07.045
pmid: 25440357
|
| 10 |
Rudolf J, Grond M, Prince WS, Schmulling S, Heiss WD. Evidence of anaphylaxy after alteplase infusion. Stroke. 1999; 30(5):1142-3.
pmid: 10229756
|
| 11 |
Campbell DJ, Krum H, Esler MD. Losartan increases bradykinin levels in hypertensive humans. Circulation. 2005; 111(3):315-20.
pmid: 15655136
|
| 12 |
Batenburg WW, Tom B, Schuijt MP, Danser AH. Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s). Vascul Pharmacol. 2005; 42(3):109-18.
doi: 10.1016/j.vph.2005.01.005
|
